Amerant is a Florida-focused regional bank pursuing organic growth through stronger deposits, selective lending, technology investment, and expansion in South Florida and Tampa. By the second quarter of 2026, deposits had reached $8.4 billion, core deposits were up 9.4% sequentially, and gross loans were up 1.7%, while management continued working through credit-quality issues.
The filing adds funding capacity, not a new strategy. Amerant priced $50 million of unsecured, unsubordinated notes at a 7.00% coupon, maturing September 17, 2031. 〔0〕 The proceeds can support organic bank growth, repay debt, or fund share repurchases, so the capital is flexible rather than tied to one identifiable investment. 〔1〕
The trade-off is a meaningful fixed funding cost. At 7%, the notes imply roughly $3.5 million of annual interest expense before any tax effects, while the filing does not disclose a specific acquisition, loan program, debt refinancing, or buyback authorization attached to the proceeds. The financing therefore improves balance-sheet flexibility but also adds recurring holding-company debt that must ultimately be supported by bank earnings or capital distributions.
This is largely a confirmation event. The release describes the offering as previously announced, and the pricing terms had already been disclosed before the September 17, 2026 filing. The incremental information is the completed pricing and expected closing, not a surprise change in Amerant's operating direction. 〔2〕
Bottom line: Amerant has secured a modest pool of flexible capital for growth, debt management, or buybacks, but at a 7% cost and without committing to a specific use. It strengthens execution capacity more than it changes the underlying business story.
Read the original 8-K on SEC EDGAR ↗